Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

32.65
Delayed Data
As of 4:00pm ET
 -0.71 / -2.13%
Today’s Change
25.27
Today|||52-Week Range
263.81
-67.88%
Year-to-Date
Tweets on the Street: Puerto Rico Defaults, Ackman Speaks, Starbucks Iced Out
5:09pm / TheStreet.com
3 Stocks Pushing The Health Care Sector Lower
Apr 27 / TheStreet.com
My Takeaways and Observations
3:08pm / TheStreet.com
This Mega-Fund Just Gobbled Up Valeant's Shares -- Should You, Too?
Apr 26 / MotleyFool.com
How Buffett Caused Valeant Stock's Latest Tumble
2:56pm / MotleyFool.com
Ackman to Testify About Valeant Before Senate
Apr 26 / GuruFocus News
Cramer Reacts to Berkshire's Amazon, Valeant Comments
1:22pm / TheStreet.com
Wall Street In Pain: 163 Hedge Funds Are Long AAPL Stock
Apr 26 / Investing Channel
Valeant Shares Destined For Major Turnaround, Bill Ackman Says
1:17pm / TheStreet.com
Valeant (VRX) Stock Up Despite Records Withholding Speculation
Apr 26 / TheStreet.com
One Reason Why Valeant (VRX) Stock Is Plummeting Today
12:28pm / TheStreet.com
Perrigo's CEO Resigns, Trims 2016 Outlook, Stock Tumbles
Apr 26 / Zacks.com
My Diagnosis of Valeant Pharmaceuticals
10:21am / TheStreet.com
Stock Market News for April 26, 2016
Apr 26 / Zacks.com
Slew Of Negative News, Defaults And Failed Mergers Push Futures In The Green
7:10am / Investing Channel
One Mutual Fund That Valeant Pharmaceuticals International Inc. Took Down With It
Apr 26 / MotleyFool.com
It's Scary Down There: Buying at the Lows
May 01 / TheStreet.com
Frontrunning: April 26
Apr 26 / Investing Channel
Cramer: The Market Needs New Leadership
Apr 29 / TheStreet.com
Another Fund Bites the Dust
Apr 26 / TheStreet.com
Cramer: Buy Valeant for a Trade Ahead of Bill Ackman's Monday TV Appearance
Apr 29 / TheStreet.com
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One
Apr 26 / TheStreet.com
Government Probes for Valeant; New Board Members Put Forth
Apr 29 / TheStreet.com
The Trader Daily: Volatility Cuts Both Ways
Apr 26 / TheStreet.com
More Squawk From Jim Cramer: Buy Valeant (VRX) Stock on Today's Weakness
Apr 29 / TheStreet.com
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One
Apr 25 / TheStreet.com
Pre-Market Laggard: Valeant Pharmaceuticals International (VRX)
Apr 29 / TheStreet.com
Valeant Pharma (VRX) Names Former Perrigo (PRGO) CEO to Fill Position
Apr 25 / Zacks.com
Tweets on the Street: Stamps.com Takes a Licking; Lessons of Manufacturing Slowdown
Apr 28 / TheStreet.com
New CEO Won't Cure What Ails Valeant
Apr 25 / TheStreet.com
Cramer: Worst May Be Over for Embattled Pharma
Apr 28 / TheStreet.com
Weitz Funds' Research Fund Commentary st Quarter
Apr 25 / GuruFocus News
Valeant's Wild Ride May Soon Be Over
Apr 28 / TheStreet.com
Questions Mount at Valeant, Perrigo Amid Executive Shuffle
Apr 25 / TheStreet.com
Valeant Pharmaceuticals' Mea Culpa May Throw the Entire Industry Under the Bus
Apr 28 / MotleyFool.com
Why Perrigo Company PLC Ordinary Shares Are Dropping Today
Apr 25 / MotleyFool.com
Board Shakeup Lifts Valeant (VRX) Shares As Jim Cramer Sees Pharma M&A on the Rise
Apr 28 / TheStreet.com
Joseph Papa Resigns As Perrigo CEO, Joins Valeants As Chairman And CEO
Apr 25 / Benzinga
Nothing Generic About This ETF's Long-Term Outlook
Apr 28 / Benzinga
Valeant (VRX) Stock Gaining, Names Perrigo's Papa as New CEO
Apr 25 / TheStreet.com
Global Stocks Plunge After Bank Of Japan "Shock"
Apr 28 / Investing Channel
Valeant Names Perrigo's Joseph Papa Chairman and CEO; Shares Jump
Apr 25 / TheStreet.com
Ackman: 'A Lot Is Going to Change' at Valeant
Apr 27 / TheStreet.com
The Michael Pearson Era Is Officially Over: Valeant Appoints Joseph Papa As Chairman ...
Apr 25 / Investing Channel
Tweets on the Street: Shkreli Tunes In for Valeant Hearing; Trump's Foreign Policy
Apr 27 / TheStreet.com
2 Value Stocks That Are Still in Play
Apr 25 / TheStreet.com
Congressional Hearing Pits Bill Ackman And Outgoing Valeant CEO Against Angry Senator...
Apr 27 / Investing Channel
The Only Way to Fix Valeant Pharmaceuticals Will Probably Disappoint Investors
Apr 22 / MotleyFool.com
Mr. Ackman Goes to Washington to Defend Drug Pricing at Valeant
Apr 27 / TheStreet.com
Valeant Pharmaceuticals: What's the Stock Worth Now?
Apr 21 / MotleyFool.com